|
DSP-0390 Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Early 1: 1
Top Sponsors
- Washington University School of Medicine1
Indications
- IDH Mutation1
- Grade II Glioma1
- Glioma, Malignant1
- Cancer1
St Louis, Missouri1 trial
Window of Opportunity Study of DSP-0390 in Gliomas
Washington University School of Medicine
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.